Does Arsenic trioxide cause cancer?

Does Arsenic trioxide cause cancer?

There have been a few reports of people developing a second cancer some years after arsenic trioxide treatment.

Is arsenic chemotherapy?

ARSENIC TRIOXIDE (AR se nik trye OX ide) is a chemotherapy drug. It slows the growth of cancer cells. This medicine is used to treat acute promyelocytic leukemia (APL).

How toxic is arsenic?

Exposure to high enough amounts of arsenic can be fatal. Exposure to lower levels of arsenic over longer periods of time can cause skin changes, liver and kidney damage, and a shortage of red and white blood cells, which can lead to fatigue and an increased risk of infections.

What is the European public assessment report (epar) for Trisenox (arsenic trioxide)?

arsenic trioxide This is a summary of the European public assessment report (EPAR) for Trisenox. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to u se Trisenox.

Is Trisenox authorised in the European Union?

This medicine is authorised for use in the European Union. This is a summary of the European public assessment report (EPAR) for Trisenox. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Trisenox.

What are the possible side effects of Trisenox?

Carcinogenesis: The active ingredient of TRISENOX, arsenic trioxide, is a human carcinogen. Monitor patients for the development of second primary malignancies. Embryo-Fetal Toxicity: TRISENOX can cause fetal harm when administered to a pregnant woman. One patient who became pregnant while receiving arsenic trioxide had a miscarriage.

Can Trisenox cause torsade de pointes?

• Cardiac Conduction Abnormalities: TRISENOX can cause QTc interval prolongation, complete atrioventricular block, and torsade de pointes, which can be fatal. Before administering TRISENOX, assess the QTc interval, correct electrolyte abnormalities, and consider discontinuing drugs known to prolong QTc interval.